Trial to Demonstrate the Safety and Effectiveness of the MiStent II for the Revascularization of Coronary Arteries.

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 1300 participants.

Also called NCT03423511

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 1,300 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT03423511
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT03423511. Randomized; single masking; primary purpose treatment. Start 2021-12-31 (anticipated); primary completion 2023-06-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Trial to Demonstrate the Safety and Effectiveness of the MiStent II for the Revascularization of Coronary Arteries.
Acronym
CRYSTAL
Intervention (Device)
MiStent II coronary artery stent
Intervention (Device)
Xience or Promus coronary artery stents
Lead sponsor
Micell Technologies (class: industry)
Collaborator
Baim Institute for Clinical Research (class: other)
Collaborator
North American Science Associates Inc. (class: not stated)
Collaborator
Yale Cardiovascular Research Group (class: other)

Record details

Record id
cardio:ct-nct03423511
Content hash
91045d6807c88d6c1f9c14a004503aa4391c63cf315a4bb4efc33c26904439ab